We found that the DEGs not only markedly participated in Hippo/Wnt, AMPK/MAPK, and TGF-β signaling pathways and animal mitophagy process, but were also involved in transcriptional misregulation and pathways in cancers, such as hepatocellular, breast, gastric, and thyroid cancer. The gene discussed is TGFB1; the disease is cancer.